Skip to main content
Back to News

News From Around the System

Despite COVID-19 Pandemic First Patient Undergoes New Personalized Immunotherapy

UC San Diego Health — December 10, 2020

Bernard Thurman was referred to a personalized cancer therapy trial at Moores Cancer Center at UC San Diego Health, a collaboration with the La Jolla Institute for Immunology, the trial employs a patient’s immune cells — specifically tumor infiltrating lymphocytes (TIL) — to destroy cancer cells.

Health Media Contacts

Find the best contact for health-related media inquiries.

View All Media Contacts